Cargando…
Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
Monoamine oxidases (MAOs) are oxidative enzymes that catalyze the conversion of biogenic amines into their corresponding aldehydes and ketones through oxidative deamination. Owing to the crucial role of MAOs in maintaining functional levels of neurotransmitters, the implications of its distorted act...
Autores principales: | Aljanabi, Reem, Alsous, Lina, Sabbah, Dima A., Gul, Halise Inci, Gul, Mustafa, Bardaweel, Sanaa K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513016/ https://www.ncbi.nlm.nih.gov/pubmed/34641563 http://dx.doi.org/10.3390/molecules26196019 |
Ejemplares similares
-
Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer
por: Bardaweel, Sanaa, et al.
Publicado: (2022) -
Molecular Investigation of the Antitumor Effects of Monoamine Oxidase Inhibitors in Breast Cancer Cells
por: Alkhawaldeh, Aseel, et al.
Publicado: (2023) -
Marine natural products with monoamine oxidase (MAO) inhibitory activity
por: Hong, Ahreum, et al.
Publicado: (2020) -
Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis
por: Yeung, Andy Wai Kan, et al.
Publicado: (2019) -
Monoamine oxidase A (MAO A) inhibitors decrease glioma progression
por: Kushal, Swati, et al.
Publicado: (2016)